Skip to main content

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

 


The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market.

Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop resilience, and creating environmentally friendly industrial processes. Innovations like gene editing, synthetic biology, and regenerative medicine continue to expand biotechnology’s applications, addressing global challenges in medicine, food security, and sustainable resource management.

Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/biotechnology-market/request-sample/

Advancements in genetic engineering and genomics to propel market demand

Advancements in genetic engineering and genomics are significantly propelling the biotechnology market by enabling precise modifications at the genetic level, fostering breakthroughs in personalized medicine, gene therapies, and biopharmaceuticals. Techniques like CRISPR-Cas9 and next-generation sequencing (NGS) have transformed disease treatment and prevention, allowing for targeted therapies that cater to individual genetic profiles. These innovations support the development of therapies for previously untreatable diseases and improve crop resilience in agriculture. Additionally, genomics-based data analytics facilitate faster drug discovery and development processes, reducing R&D costs and time-to-market. This precision and efficiency are attracting substantial investments across the biotechnology sector.

Growing demand for biopharmaceuticals is driving the market growth

The growing demand for biopharmaceuticals is a major driver of biotechnology market growth, as biologic drugs like monoclonal antibodies, vaccines, and cell therapies offer targeted treatments with fewer side effects compared to traditional medications. Biopharmaceuticals are particularly effective in treating complex chronic diseases, including cancer, autoimmune disorders, and genetic conditions. Their efficacy and specificity are fueling global demand, prompting biopharma companies to expand R&D investments. Additionally, advancements in biotechnology, such as recombinant DNA technology and advanced bio-manufacturing processes, enable efficient biopharmaceutical production, supporting rapid market expansion and the development of more personalized, high-impact therapies.

Get exclusive insights - download your sample report today 
https://meditechinsights.com/biotechnology-market/request-sample/

Competitive Landscape Analysis

The global biotechnology market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA; among others. Some of the key strategies adopted by market players include new product and service development, strategic partnerships and collaborations, and geographic expansion.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more